Assessing and managing women with heavy menstrual bleeding

The definition of heavy menstrual bleeding (HMB) has changed – it is no longer solely defined by millilitres of blood loss per cycle but now includes the impact on a women’s physical, social and emotional quality of life.1


of women say that HMB affects their relationship with their partner or their performance at work, and it affects attendance at school or work for 68% of sufferers.2

As many as 1 in 3 women are expected to be negatively affected by HMB during their life but knowledge of the condition is poor.2,3 As such, many women are unaware that there are treatment options available for HMB2 – you can help her to speak up with three key questions:


See how these same three questions can help you to determine individualised treatment plans for your patients through these case studies

Case studies

Once ‘bothersome bleeding’ has been identified, follow the HELP diagnostic pathway for HMB

*You may wish to consider other treatments after trial of pharmaceutical options as per NICE guidelines: NICE Heavy Menstrual Bleeding NG88, 2018.


The HELP group is an expert panel of physicians from 12 countries with a special interest in heavy menstrual bleeding (HMB), supported by Bayer.

Download the interactive HELP treatment algorithm, including clinical considerations for all approved treatment options


Qlaira® Prescribing Information, Mirena® Prescribing Information,



The HELP group is an expert panel of physicians from 12 countries with a special interest in heavy menstrual bleeding (HMB), supported by Bayer.

NICE recommends Mirena® as a first-line pharmaceutical treatment for HMB with no identified pathology.1

  • Provides effective relief from idiopathic menorrhagia.2
  • Achieves menstrual blood loss reduction of up to 96%.3
  • Reduced bleeding promotes the increase of blood haemoglobin levels.2
  • Improves quality of life more than usual medical treatments (tranexamic acid, mefenamic acid, combined oestrogen-progestogen or progesterone alone).4
  • Totally or occasionally absent menstruation has been associated with prolonged continuation with Mirena®.5
  • May effectively manage bleeding problems during the transition through menopause.6
MIrena levonorgestrel

Heavy Menstrual Bleeding (HMB): evidence-based learning for best practice.

A 30-minute, scientific e-learning course developed by the HELP expert panel of independent physicians*. Three case-based modules cover the diagnostic pathway and treatment algorithm for HMB to help you to counsel your patients effectively.


*The formation of the HELP expert panel and its ongoing work is supported by Bayer AG.

Gain real-world patient insights into heavy menstrual bleeding through this short video that can help both you and your patients relate to the condition.

Reporting adverse events and quality complaints

If you want to report a side effect or quality complaint, please contact your health care professional (e.g. physician or pharmacist) or The Health Products Regulatory Authority, Reports can also be reported directly to Bayer through this link or by emailing directly on